NATPAR

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, UK.

Active ingredients

The drug NATPAR contains one active pharmaceutical ingredient (API):

1	Parathyroid hormone UNII N19A0T0E5J - PARATHYROID HORMONE
	Endogenous parathyroid hormone (PTH) is secreted by the parathyroid glands as a polypeptide of 84 amino acids. PTH exerts its action via cell-surface parathyroid hormone receptors, present in bone, kidney and nerve tissue. PTH has a variety of critical physiological functions that include its central role in modulating serum calcium and phosphate levels within tightly regulated levels, regulating renal calcium and phosphate excretion, activating vitamin D, and maintaining normal bone turnover.
	Read more about Parathyroid hormone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NATPAR Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H05AA03	Parathyroid hormone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05A Parathyroid hormones and analogues → H05AA Parathyroid hormones and analogues
Discover more medicines within H05AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1744433, 1744444, 1744455, 1744466
FI	Lääkealan turvallisuus- ja kehittämiskeskus	110022, 411084, 494510, 522412
GB	Medicines & Healthcare Products Regulatory Agency	348251, 348262, 348277, 348282
IT	Agenzia del Farmaco	045375019, 045375021, 045375033, 045375045
LT	Valstybinė vaistų kontrolės tarnyba	1082782, 1082783, 1082784, 1082785
NL	Z-Index G-Standaard, PRK	150010, 150029, 150037, 82198
PL	Rejestru Produktów Leczniczych	100418110, 100418127, 100418133, 100418140
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68220001, W68221001, W68222001, W68223001